Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 38 Melanoma 15 Neoplasm Metastasis 12 Squamous Cell Carcinoma of Head and Neck 11 Lung Neoplasms 11 Skin Neoplasms 10 Neoplasms 9 Ovarian Neoplasms 8 Recurrence 7 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Urinary Bladder Neoplasms 6 Head and Neck Neoplasms 6 Carcinoma, Basal Cell 6 Breast Neoplasms 6 Adenocarcinoma 6 Uterine Cervical Neoplasms 5 Triple Negative Breast Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Squamous Cell 5 Carcinoma, Merkel Cell 5 Carcinoma 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Mouth Neoplasms 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Stomach Neoplasms 3 Sarcoma 3 Mycosis Fungoides 3

Interventions

pembrolizumab 4 aldesleukin 3 Cisplatin 3 lenvatinib 2 Surveys and Questionnaires 2 Specimen Handling 2 Paclitaxel 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Adoptive Transfer 2 zimberelimab 1 trastuzumab deruxtecan 1 tivozanib 1 liposomal doxorubicin 1 fludarabine phosphate 1 fludarabine 1 entinostat 1 dostarlimab 1 cemiplimab 1 bintrafusp alfa protein, human 1 belzutifan 1 atezolizumab 1 Therapeutic Touch 1 Taxes 1 Standard of Care 1 Sonazoid 1 Respiratory Function Tests 1 Radiotherapy 1 Radiation 1 Prochlorperazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Vulvar Neoplasms × cemiplimab × 1 year × Clear all

NCT07101848 2025-08-03

BRAVA VULVAR

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡